Laurus Labs, Slovenia's KrKa ink pact to set up JV firm in Hyderabad

Laurus Labs has entered into an agreement with Slovenia-based drug manufacturer Krka to establish a joint venture (JV) firm in Hyderabad. Under the agreement, Krka will hold a 51% stake, while Laurus Labs will hold 49%. The JV, with a registered capital equivalent to €50 million, aims to produce finished products for new markets, including India.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news